RE:RE:Re re re re re this board was dead"In the transcripts of the earnings call, it is made clear that the consultant can not be engaged until H2". Possible misprint by SA??? HAS ALREADY with CC March 15th sounds like currently working.....JMO
"We have brought on board an industry expert in the pharmaceutical sector, a 15-year former partner who specialized in pharmaceutical consulting at the Boston Consulting Group.
Together with the Company's executives HAS ALREADY kicked off the process, which will lead us to the completion of a long-term strategic growth plan.
We will be working hard in the first half of 2017 fully studying the business transformation options available to us and anticipate sharing the key pillars of our long-term growth strategy in the second half of the year".